New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Genetic analysis tool developed to improve cancer modeling

Genetic analysis tool developed to improve cancer modeling

byArizona State UniversityGraphical Abstract. Credit:Cell Reports Methods(2023). DOI: 10.1016/j.crmeth.2023.100442Lifestyle behaviors such as eating well and exercising can be signif
World medicine December 04,2023
Genetic analysis tool developed to improve cancer modeling

Genetic analysis tool developed to improve cancer modeling

byArizona State UniversityGraphical Abstract. Credit:Cell Reports Methods(2023). DOI: 10.1016/j.crmeth.2023.100442Lifestyle behaviors such as eating well and exercising can be signif
World medicine December 04,2023
New immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease

New immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous
World medicine December 04,2023
New immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease

New immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous
World medicine December 04,2023
Study reveals epigenetic vulnerability of acute myeloid leukemia

Study reveals epigenetic vulnerability of acute myeloid leukemia

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-2129Acute myeloid leukemia (AML) is an aggressive blood cancer
World medicine December 04,2023
Study reveals epigenetic vulnerability of acute myeloid leukemia

Study reveals epigenetic vulnerability of acute myeloid leukemia

by Molly Chiu,Baylor College of MedicineGraphical abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-2129Acute myeloid leukemia (AML) is an aggressive blood cancer
World medicine December 04,2023
PANDORA test could pave the way for better oral cancer detection

PANDORA test could pave the way for better oral cancer detection

byUniversity of SurreyFlow chart of study participants. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13417Surrey scientists have developed a proof-of-conce
World medicine December 04,2023
PANDORA test could pave the way for better oral cancer detection

PANDORA test could pave the way for better oral cancer detection

byUniversity of SurreyFlow chart of study participants. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13417Surrey scientists have developed a proof-of-conce
World medicine December 04,2023
Combination treatment shows significant reduction in disease growth in patients with advanced endometrial cancer

Combination treatment shows significant reduction in disease growth in patients with advanced endometrial cancer

by Michelle Brubaker,University of California - San DiegoIn a study published in theNew England Journal of Medicine, researchers at the UC San Diego School of Medicine and Moores Cancer Ce
World medicine December 04,2023
Combination treatment shows significant reduction in disease growth in patients with advanced endometrial cancer

Combination treatment shows significant reduction in disease growth in patients with advanced endometrial cancer

by Michelle Brubaker,University of California - San DiegoIn a study published in theNew England Journal of Medicine, researchers at the UC San Diego School of Medicine and Moores Cancer Ce
World medicine December 04,2023
Using the right test for the right person to detect bowel cancer

Using the right test for the right person to detect bowel cancer

by Professor Jon Emery and Dr Sibel Saya,University of MelbourneCredit: AI-generated imageDespite Australia and New Zealand having one of thehighest rates of bowel cancerin the world
World medicine December 04,2023
Using the right test for the right person to detect bowel cancer

Using the right test for the right person to detect bowel cancer

by Professor Jon Emery and Dr Sibel Saya,University of MelbourneCredit: AI-generated imageDespite Australia and New Zealand having one of thehighest rates of bowel cancerin the world
World medicine December 04,2023
Rapid genetic testing targets advanced prostate cancer patients for new treatments

Rapid genetic testing targets advanced prostate cancer patients for new treatments

byWolters Kluwer HealthMainstreaming model. Patients were approached by their treating oncologist in the clinic to undergo genetic testing. Pretest education consisted of a written brochure and
World medicine December 04,2023
Rapid genetic testing targets advanced prostate cancer patients for new treatments

Rapid genetic testing targets advanced prostate cancer patients for new treatments

byWolters Kluwer HealthMainstreaming model. Patients were approached by their treating oncologist in the clinic to undergo genetic testing. Pretest education consisted of a written brochure and
World medicine December 04,2023
Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

byRegenstrief InstituteCredit: Unsplash/CC0 Public DomainManaging symptoms improves quality of life. Sleep disturbance, pain, physical function impairment, anxiety, depression, and low energy/fa
World medicine December 04,2023
Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

byRegenstrief InstituteCredit: Unsplash/CC0 Public DomainManaging symptoms improves quality of life. Sleep disturbance, pain, physical function impairment, anxiety, depression, and low energy/fa
World medicine December 04,2023
Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

by The GOG Foundation IncCredit: Pixabay/CC0 Public DomainThe GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating t
World medicine December 04,2023
Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

by The GOG Foundation IncCredit: Pixabay/CC0 Public DomainThe GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating t
World medicine December 04,2023
A cancer-wide analysis finds cancer-wide targets for tumor reduction

A cancer-wide analysis finds cancer-wide targets for tumor reduction

by Justin Jackson , Medical Xpress\Cell line expression of tumor-specific TE-chimeric transcripts. a, Box plots with overlaid dot plots of the number of candidates expressed in each cancer cell line p
World medicine December 04,2023
A cancer-wide analysis finds cancer-wide targets for tumor reduction

A cancer-wide analysis finds cancer-wide targets for tumor reduction

by Justin Jackson , Medical Xpress\Cell line expression of tumor-specific TE-chimeric transcripts. a, Box plots with overlaid dot plots of the number of candidates expressed in each cancer cell line p
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com